PharVision Advisers’s Chord Energy CHRD Stock Holding History

PharVision Advisers’s Portfolio CHRD Stock Details CHRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,412	Closed	-$272K	–	292
2025 Q1	$272K	Buy	+2,412	New	+$274K	0.38%	114

Other funds holding CHRD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return

PharVision Advisers's CHRD Position: Q2 2025 in Review

PharVision Advisers sold out of Chord Energy (CHRD) in Q2 2025, closing a stake of 2,412 shares — an estimated $272K sold.

PharVision Advisers first reported a position in CHRD in Q1 2025 and held it in 1 quarter. The position peaked at $272K in Q1 2025. 440 funds tracked by Wall St. Rank hold CHRD as of Q2 2025.

PharVision Advisers reported no remaining Chord Energy position as of Q2 2025 after selling out during the quarter.
PharVision Advisers sold 2,412 Chord Energy shares in Q2 2025, an estimated $272K.
PharVision Advisers first reported a position in Chord Energy in Q1 2025 and held it in 1 quarter.
PharVision Advisers's Chord Energy position peaked at $272K in Q1 2025.
440 funds tracked by Wall St. Rank held Chord Energy as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.